Improving the Cost-efficiency of Preventive Chemotherapy: Impact of New Diagnostics on Stopping Decisions for Control of Schistosomiasis.
Luc E CoffengMatthew GrahamRaiha BrowningKlodeta KuraPeter J DiggleMatthew DenwoodGraham F MedleyRoy M AndersonSake J de VlasPublished in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2024)
We conclude that the potential value of more sensitive diagnostics lies more in the reduction of survey-related costs than in the direct health impact of improved parasite control.